| Literature DB >> 29689716 |
Joeke van Santen1,2, Rose-Marie Dröes1,2, Marije Holstege3, Olivier Blanson Henkemans4, Annelies van Rijn1,2, Ralph de Vries5, Annemieke van Straten6, Franka Meiland1,2.
Abstract
BACKGROUND: Physical exercise benefits functioning, health, and well-being. However, people living with dementia in particular hardly engage in exercise. Exergaming (exercise and gaming) is an innovative, fun, and relatively safe way of exercising in a virtual reality or gaming environment. It may help people living with dementia overcome barriers they can experience regarding regular exercise activities.Entities:
Keywords: Cognition; dementia; exercise; neuropsychiatry; play; quality of life; review
Mesh:
Year: 2018 PMID: 29689716 PMCID: PMC5929299 DOI: 10.3233/JAD-170667
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472
Fig.1Selection process of the systematic review (from: Moher et al., 2009) [43].
Study and intervention characteristics
| Study | Design &aims/hypothesis | Participants &setting | Dementia diagnosis & severity (incl. type(s) of dementia), comorbidities | Exergaming intervention | Control/comparison |
| Bamidis et al. [ | |||||
| Padala et al. [ | |||||
| Padala et al. [ | |||||
IG, intervention group; CG, comparison/control group; AD, Alzheimer’s disease; MCI, mild cognitive impairment; BMI, body mass index; MMSE, Mini-Mental State Examination.
Outcome measures and between group effects* on physical functioning by study and different comparison/control groups (if applicable)
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Passive control group | Exergaming | Passive control group | ANCOVA** | Effect size | ||||
| Bamidis et al. [ | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-passive control group (95% CI) | (Cohen’s | |||
| Subtests of the Senior Fitness Test (SFT)***: | |||||||||
| SFT-Chair stand | 13.8 (3.1) | 10.5 (3.1) | 19.3 (4.6) | 9.3 (1.5) | 14.4 (10.2 to 18.7) | 0.152 | 2.70 | ||
| SFT-Arm curl | 19.8 (7.3) | 16.0 (4.2) | 24.8 (4.3) | 14.3 (3.1) | 19.7 (16.8 to 22.7) | 2.72 | |||
| SFT-2-min step | 61.8 (19.9) | 68.5 (23.9) | 81.0 (9.2) | 69.0 (24.3) | 74.9 (66.7 to 83.1) | 0.082 | 0.71 | ||
| SFT-Back scratch | 0.3 (7.2) | –9.8 (9.3) | 0.0 (6.8) | –13.0 (5.6) | –5.8 (–7.2 to –4.4) | 0.135 | 2.06 | ||
| SFT-Chair sit-and-reach | 0.8 (7.7) | 2.3 (7.5) | 4.0 (6.9) | 0.0 (8.7) | 1.9 (–1.1 to 4.9) | 0.074 | 0.52 | ||
| SFT-8-foot up-and-go | 5.5 (1.7) | 7.5 (2.3) | 4.7 (0.9) | 7.4 (0.5) | 5.9 (5.6 to 6.3) | –3.26 | |||
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Active control group | Exergaming | Active control group | ANCOVA** | Effect size | ||||
| Bamidis et al. [ | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-active control group (95% CI) | (Cohen’s | |||
| Subtests of the Senior Fitness Test (SFT)***: | |||||||||
| SFT-Chair stand | 13.8 (3.1) | 12.3 (1.8) | 19.3 (4.6) | 12.8 (1.5) | 15.9 (13.6 to 18.4) | 2.12 | |||
| SFT-Arm curl | 19.8 (7.3) | 18.5 (3.2) | 24.8 (4.3) | 18.8 (3.3) | 21.7 (19.4 to 24.1) | 1.60 | |||
| SFT-2-min step | 61.8 (19.9) | 63.7 (19.8) | 81.0 (9.2) | 67.0 (18.3) | 74.1 (66.3 to 81.9) | 0.056 | 0.90 | ||
| SFT-Back scratch | 0.3 (7.2) | –12.8 (9.1) | 0.0 (6.8) | –12.3 (7.7) | –7.2 (–9.1 to –5.3) | 0.401 | 1.67 | ||
| SFT-Chair sit-and-reach | 0.8 (7.7) | 2.7 (3.2) | 4.0 (6.9) | 2.2 (2.9) | 3.3 (0.3 to 6.3) | 0.191 | 0.38 | ||
| SFT-8-foot up-and-go | 5.5 (1.7) | 5.7 (2.3) | 4.7 (0.9) | 6.3 (1.5) | 5.5 (4.5 to 6.5) | 0.122 | –1.22 | ||
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Cognitive intervention | Exergaming | Cognitive intervention | ANCOVA** | Effect size | ||||
| Bamidis et al. [ | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-cognitive group (95% CI) | (Cohen’s | |||
| Subtests of the Senior Fitness Test (SFT)***: | |||||||||
| SFT-Chair stand | 13.8 (3.1) | 10.0 (2.8) | 19.3 (4.6) | 12.0 (6.1) | 15.6 (11.1 to 20.1) | 0.349 | 1.35 | ||
| SFT-Arm curl | 19.8 (7.3) | 12.8 (2.6) | 24.8 (4.3) | 12.8 (3.8) | 18.6 (16.1 to 21.1) | 2.97 | |||
| SFT-2-min step | 61.8 (19.9) | 39.4 (18.2) | 81.0 (9.2) | 38.0 (10.8) | 59.5 (52.5 to 66.5) | 4.29 | |||
| SFT-Back scratch | 0.3 (7.2) | –17.6 (11.2) | 0.0 (6.8) | –15.6 (11.3) | –8.7 (–12.2 to –5.2) | 0.982 | 1.62 | ||
| SFT-Chair sit-and-reach | 0.8 (7.7) | –3.2 (10.3) | 4.0 (6.9) | 1.6 (15.9) | 2.6 (–3.7 to 9.0) | 0.938 | 0.19 | ||
| SFT-8-foot up-and-go | 5.5 (1.7) | 9.7 (2.7) | 4.7 (0.9) | 7.4 (2.4) | 6.1 (4.5 to 7.7) | 0.412 | –1.40 | ||
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Comparison | Exergaming | Comparison | Exergaming | Comparison | Independent samples | |||
| Padala et al. [ | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Change (mean (SD)) | Change (mean (SD)) | Difference (95% CI) | (95% CI) (Cohen’s | |
| Berg Balance Scale (max. poss. score: 56) | 43.4 (8.9) | 41.3 (7.6) | 49.6 (5.7) | 46.6 (8.7) | 6.2 (7.5) | 5.3 (8.2) | 1.0 (–5.9 to 7.9) | 0.768 | 0.41 |
| Tinetti Test (max. poss. score: 28) | 23.5 (3.7) | 22.9 (2.6) | 25.3 (2.8) | 24.9 (3.4) | 1.8 (3.3) | 2.0 (3.0 | –0.2 (–3.0 to 2.6) | 0.883 | 0.13 |
| Timed Up and Go (in s) | 14.7 (7.2) | 14.9 (4.7) | 13.9 (7.9) | 12.8 (3.2) | –0.8 (7.6) | –2.1 (4.0) | 1.3 (–4.1 to 6.7) | 0.621 | 0.18 |
| Padala et al. [ | Score (mean (SD)) | Score (mean (SD)) | Exergaming group: change (mean (95% CI)) | Comparison group: change (mean (95% CI)) | Difference (95% CI) | Effect size (Cohen’s | |||
| Berg Balance Scale (max. poss. score: 56) | 46.5 (2.4) | 45.8 (2.5) | 5.8 (4.8 to 6.8) | 1.0 (0.0 to 2.0) | 4.8 (3.3 to 6.2) | < | 2.24 | ||
*Statistically significant between group effects (p≤0.05) are printed in bold. **Mean differences between exergaming and control/comparison group resulting from the ANCOVA analysis. ***Subtests of the Senior Fitness Test (SFT) [61]: SFT-Chair stand: testing lower body strength by the number of completed chair stands in 30 seconds. SFT-Arm curl: testing upper body strength by the number of arm curls in 30 seconds using the dominant arm. SFT-2-min step: measuring aerobic endurance by the number of steps in 2 minutes. SFT-Back scratch: testing upper body flexibility by measuring the distance between the tips of the middle fingers. If the fingertips touch then the score is zero. If they do not touch, the distance between the fingertips is measured resulting in a negative score. If they overlap, it is measured by how much resulting in a positive score. All scores are in centimeters. SFT-Chair sit-and-reach: testing lower body flexibility by measuring the distance between the tip of the fingertips and the toes. If the toes are reached, the score is zero. If the toes cannot be reached, this results in a negative score. If a participant can reach further than the toes, this results in a positive score. All scores are in centimeters. SFT-8-foot up-and-go: measuring speed, agility and balance while moving, scores are in seconds.
Outcome measures and between group effects* on quality of life by study and different comparison/control groups (if applicable)
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Passive control group | Exergaming | Passive control group | ANCOVA** | Effect size | ||||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-passive control group (95% CI) | (Cohen’s | ||||
| Short version of the World Health Organization Quality of Life questionnaire*** | 54.0 (5.2) | 60.7 (4.2) | 57.2 (8.8) | 58.3 (4.6) | 57.7 (48.9 to 66.5) | 0.962 | –0.15 | ||
| Exergaming | Active control group | Exergaming | Active control group | ANCOVA** | Effect size | ||||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-active control group (95% CI) | (Cohen’s | ||||
| Short version of the World Health Organization Quality of Life questionnaire*** | 54.0 (5.2) | 54.5 (8.2) | 57.2 (8.8) | 56.7 (7.4) | 56.9 (50.7 to 63.2) | 0.892 | 0.06 | ||
| Exergaming | Cognitive intervention | Exergaming | Cognitive intervention | ANCOVA** | Effect size | ||||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-cognitive group (95% CI) | (Cohen’s | ||||
| Short version of the World Health Organization Quality of Life questionnaire*** | 54.0 (5.2) | 45.3 (12.5) | 57.2 (8.8) | 50.7 (15.5) | 53.5 (45.9 to 61.1) | 0.800 | 0.50 | ||
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Comparison | Exergaming | Comparison | Exergaming | Comparison | Independent samples | |||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Change (mean (SD)) | Change (mean (SD)) | Difference (95% CI) | Effect size (Cohen’s | ||
| Quality of Life-AD**** | 36.5 (3.3) | 37.3 (4.9) | 35.9 (2.8) | 35.6 (5.6) | –0.6 (3.1) | –1.7 (5.3) | 1.1 (–2.7 to 4.9) | 0.559 | 0.07 |
| Score (mean (SD)) | Score (mean (SD)) | Exergaming group: change (mean (95% CI)) | Comparison group: change (mean (95% CI)) | Difference (95% CI) | Effect size (Cohen’s | ||||
| Quality of Life-AD**** | 36.8 (3.5) | 37.2 (3.0) | 1.7 (0.6 to 2.8) | 1.1 (0.0 to 2.3) | 0.6 (–1.0 to 2.2) | 0.445 | Effect size (Cohen’s | ||
*No statistically significant between group effects (p≤0.05) were found. **Mean differences between exergaming and control/comparison group resulting from the ANCOVA analysis. ***Short version of the World Health Organization Quality of Life questionnaire [68]: maximum possible score is 130 with a higher score indicating a higher quality of life. ****Quality of Life-AD [65]: maximum possible score is 52 with a higher score indicating a higher quality of life.
Outcome measures and between group effects* on cognitive functioning by study and different comparison/control groups (if applicable)
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Passive control group | Exergaming | Passive control group | ANCOVA** | Effect size | ||||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-passive control group (95% CI) | (Cohen’s | ||||
| Mini-Mental State Examination | 22.3 (1.5) | 22.0 (3.2) | 23.5 (1.3) | 24.0 (4.2) | 23.8 (21.9 to % 25.5) | 0.602 | –0.16 | ||
| California Verbal Learning Test (CVLT)***: | |||||||||
| CVLT-Short delay free recall | 3.3 (3.3) | 3.8 (4.4) | 7.3 (3.6) | 3.8 (4.5) | 5.5 (3.5 to 7.5) | 0.056 | 0.86 | ||
| CVLT-Short delay cued recall | 5.0 (2.9) | 6.0 (2.6) | 8.3 (4.4) | 7.5 (2.7) | 7.9 (6.8 to 8.9) | 0.069 | 0.21 | ||
| CVLT-Long delay free recall | 1.8 (2.1) | 3.5 (2.9) | 6.5 (4.4) | 4.3 (3.1) | 5.4 (3.1 to 7.7) | 0.071 | 0.59 | ||
| CVLT-Long delay cued recall | 5.0 (3.5) | –7.3 (5.7) | 7.8 (3.9) | 7.0 (3.7) | 7.4 (4.8 to 9.9) | 0.376 | 0.20 | ||
| CVLT-Recognition | 11.3 (2.1) | 12.0 (4.3) | 13.3 (3.1) | 13.3 (3.2) | 13.3 (10.6 to 15.9) | 0.862 | 0.00 | ||
| Digit Span Test (DST) (no. of digits): | |||||||||
| DST-Forward | 4.0 (1.4) | 5.8 (1.5) | 4.0 (1.6) | 5.3 (2.1) | 4.6 (3.3 to 5.9) | 0.825 | –0.66 | ||
| DST-Backward | 2.3 (0.5) | 2.8 (1.0) | 3.5 (1.0) | 3.3 (1.3) | 3.4 (2.4 to 4.4) | 0.936 | 0.22 | ||
| Trail Making Test part A &B (TMT A &B): | |||||||||
| TMT A time (in s) | 196.3 (110.1) | 104.0 (76.8) | 124.8 (50.9) | 64.3 (33.1) | 98.6 (72.4 to 124.8) | 0.879 | 1.35 | ||
| TMT A (no. of) errors | 1.0 (0.8) | 2.0 (2.8) | 0.8 (0.5) | 0.7 (0.6) | 0.7 (–0.4 to 1.9) | 0.840 | 0.07 | ||
| TMT B time (in s) | 299.3 (62.7) | 218.3 (104.6) | 331.0 (129.9) | 173.3 (97.9) | 252.2 (126.4 to 377.9) | 0.426 | 1.37 | ||
| TMT B (no. of) errors | 1.7 (0.6) | 0.7 (0.6) | 1.7 (2.1) | 0.7 (0.6) | 1.2 (–1.1 to 3.5) | 0.743 | 0.65 | ||
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Active control group | Exergaming | Active control group | ANCOVA** | Effect size | ||||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-active control group (95% CI) | (Cohen’s | ||||
| Mini-Mental State Examination | 22.3 (1.5) | 19.2 (6.4) | 23.5 (1.3) | 19.2 (3.9) | 21.2 (19.6 to 22.7) | 0.800 | 1.37 | ||
| California Verbal Learning Test (CVLT)***: | |||||||||
| CVLT-Short delay free recall | 3.3 (3.3) | 2.6 (2.2) | 7.3 (3.6) | 4.6 (1.8) | 5.9 (4.4 to 7.3) | 0.132 | 0.97 | ||
| CVLT-Short delay cued recall | 5.0 (2.9) | 4.8 (1.5) | 8.3 (4.4) | 6.0 (3.1) | 7.1 (4.8 to 9.4) | 0.322 | 0.61 | ||
| CVLT-Long delay free recall | 1.8 (2.1) | 2.4 (1.8) | 6.5 (4.4) | 3.0 (2.1) | 4.8 (3.0 to 6.6) | 1.05 | |||
| CVLT-Long delay cued recall | 5.0 (3.5) | 3.6 (1.7) | 7.8 (3.9) | 4.8 (2.6) | 6.2 (4.4 to 8.0) | 0.335 | 0.92 | ||
| CVLT-Recognition | 11.3 (2.1) | 13.2 (1.5) | 13.3 (3.1) | 14.0 (1.0) | 13.7 (11.8 to 15.5) | 0.979 | –0.35 | ||
| Digit Span Test (DST) (no. of digits): | |||||||||
| DST-Forward | 4.0 (1.4) | 3.8 (1.5) | 4.0 (1.6) | 4.2 (1.5) | 4.1 (3.2 to 4.9) | 0.627 | –0.13 | ||
| DST-Backward | 2.3 (0.5) | 3.0 (1.0) | 3.5 (1.0) | 3.2 (0.8) | 3.4 (2.8 to 3.9) | 0.174 | 0.33 | ||
| Trail Making Test part A &B (TMT A &B): | |||||||||
| TMT A time (in s) | 196.3 (110.1) | 129.2 (43.6) | 124.8 (50.9) | 121.2 (33.4) | 121.2 (130.9 to 138.5) | 0.126 | 0.08 | ||
| TMT A (no. of) errors | 1.0 (0.8) | 0.2 (0.5) | 0.8 (0.5) | 0.2 (0.5) | 0.4 (–0.3 to 1.2) | 0.745 | 0.53 | ||
| TMT B time (in s) | 299.3 (62.7) | 308.7 (170.7) | 331.0 (129.9) | 333.5 (153.1) | 333.5 (208.9 to 458.1) | 0.953 | –0.03 | ||
| TMT B (no. of) errors | 1.7 (0.6) | 4.0 (3.5) | 1.7 (2.1) | 3.7 (3.1) | 2.7 (0.3 to 5.0) | 0.981 | –0.76 | ||
| Mini-Mental State Examination | 22.3 (1.5) | 20.8 (2.3) | 23.5 (1.3) | 23.4 (3.4) | 23.4 (21.4 to 25.4) | 0.596 | 1.37 | ||
| California Verbal Learning Test (CVLT)***: | |||||||||
| CVLT-Short delay free recall | 3.3 (3.3) | 5.8 (4.1) | 7.3 (3.6) | 9.2 (4.3) | 8.4 (6.4 to 10.4) | 0.879 | –0.49 | ||
| CVLT-Short delay cued recall | 5.0 (2.9) | 6.8 (3.7) | 8.3 (4.4) | 9.6 (3.6) | 9.0 (7.9 to 10.1) | 0.531 | –0.34 | ||
| CVLT-Long delay free recall | 1.8 (2.1) | 6.4 (4.9) | 6.5 (4.4) | 8.2 (4.3) | 7.6 (4.8 to 10.3) | 0.514 | –0.39 | ||
| CVLT-Long delay cued recall | 5.0 (3.5) | 7.0 (4.0) | 7.8 (3.9) | 8.2 (4.3) | 8.1 (5.9 to 10.3) | 0.526 | –0.11 | ||
| CVLT-Recognition | 11.3 (2.1) | 13.2 (3.1) | 13.3 (3.1) | 12.8 (3.6) | 13.1 (10.8 to 15.5) | 0.387 | 0.13 | ||
| Digit Span Test (DST) (no. of digits): | |||||||||
| DST-Forward | 4.0 (1.4) | 4.0 (1.9) | 4.0 (1.6) | 4.8 (1.1) | 4.4 (3.5 to 5.4) | 0.336 | –0.59 | ||
| DST-Backward | 2.3 (0.5) | 2.8 (0.8) | 3.5 (1.0) | 3.4 (0.9) | 3.5 (2.7 to 4.2) | 0.583 | 0.11 | ||
| Trail Making Test part A &B (TMT A &B): | |||||||||
| TMT A time (in s) | 196.3 (110.1) | 151.0 (29.1) | 124.8 (50.9) | 120.4 (59.4) | 16.2 (81.8 to 161.1) | 0.660 | 0.08 | ||
| TMT A (no. of) errors | 1.0 (0.8) | 0.4 (0.6) | 0.8 (0.5) | 0.4 (0.9) | 0.6 (–0.4 to 1.5) | 0.946 | 0.29 | ||
| TMT B time (in s) | 299.3 (62.7) | 304.0 (66.1) | 331.0 (129.9) | 258.8 (70.5) | 287.8 (140.8 to 434.9) | 0.405 | 0.80 | ||
| TMT B (no. of) errors | 1.7 (0.6) | 2.3 (1.5) | 1.7 (2.1) | 0.5 (0.6) | 1.0 (–0.3 to 3.3) | 0.434 | 0.87 | ||
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Comparison | Exergaming | Comparison | Exergaming | Comparison | Independent samples | |||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Change (mean (SD)) | Change (mean (SD)) | Difference (95% CI) | Effect size (Cohen’s | ||
| Mini Mental State Examination | 22.6 (4.3) | 24.9 (3.6) | 22.4 (2.8) | 25.5 (4.1) | –0.2 (3.6) | 0.6 (3.9) | –0.8 (–4.1 to 2.5) | 0.623 | –0.88 |
| Score (mean (SD)) | Score (mean (SD)) | Exergaming group: change (mean (95% CI)) | Comparison group: change (mean (95% CI)) | Difference (95% CI) | Effect size (Cohen’s | ||||
| Mini-Mental State Examination | 23.3 (2.2) | 22.7 (2.3) | 0.7 (–0.3 to 1.7) | –0.1 (–1.1 to 0.9) | 0.8 (–0.7 to 2.2) | 0.264 | 0.00 | ||
| Modified Mini Mental (max. poss. score: 100) | 87.5 (3.6) | 85.7 (7.8) | –0.4 (–2.6 to 1.7) | –0.6 (–2.7 to 1.6) | 0.1 (–3.0 to 3.2) | 0.946 | 0.33 | ||
*Statistically significant between group effects (p≤0.05) are printed in bold. **Mean differences between exergaming and control/comparison group resulting from the ANCOVA analysis. ***California Verbal Learning Test (CVLT) [62]: testing episodic verbal learning and memory. All scores are in number of words, maximum possible score is 16 per subtest.
Outcome measures and between group effects* on daily life functioning by study and different comparison/control groups (if applicable)
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Passive control group | Exergaming | Passive control group | ANCOVA** | Effect size | ||||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-passive control group (95% CI) | (Cohen’s | ||||
| Instrumental Activities of Daily Living Scale*** | 8.0 (0.0) | 6.5 (1.7) | 8.0 (0.0) | 6.5 (1.7) | 7.3 (7.3 to 7.3) | < | 1.23 | ||
| Exergaming | Active control group | Exergaming | Active control group | ANCOVA** | Effect size | ||||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-active | (Cohen’s | ||||
| control group (95% CI) | |||||||||
| Instrumental Activities of Daily Living Scale*** | 8.0 (0.0) | 6.8 (1.6) | 8.0 (0.0) | 8.3 (4.0) | 7.3 (7.3 to 7.3) | < | 0.97 | ||
| Exergaming | Cognitive intervention | Exergaming | Cognitive intervention | ANCOVA** | Effect size | ||||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-cognitive group (95% CI) | (Cohen’s | ||||
| Instrumental Activities of Daily Living Scale*** | 8.0 (0.0) | 8.0 (0.0) | 8.0 (0.0) | 7.8 (0.5) | 7.9 (7.6 to 8.2) | 0.407 | 0.59 | ||
| Baseline | Follow up at 8 weeks | ||||||||
| Exergaming | Comparison | Exergaming | Comparison | Exergaming | Comparison | Independent samples | |||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Change (mean (SD)) | Change (mean (SD)) | Difference (95% CI) | Effect size (Cohen’s | ||
| Activities of Daily Living**** | 22.3 (1.6) | 22.0 (2.7) | 22.6 (1.3) | 21.4 (2.5) | 0.3 (1.5) | –0.6 (2.6) | 0.9 (–0.9 to 2.8) | 0.332 | 0.60 |
| Instrumental Activities of Daily Living*** | 11.3 (4.3) | 10.9 (3.5) | 10.4 (2.8) | 11.6 (4.2) | –0.9 (3.6) | 0.7 (3.9) | –1.6 (–4.9 to 1.7) | 0.329 | –0.34 |
| Score (mean (SD)) | Score (mean (SD)) | Exergaming group: change (mean (95% CI)) | Comparison group: change (mean (95% CI)) | Difference (95% CI) | Effect size (Cohen’s | ||||
| Activities of Daily Living**** | 23.4 (1.1) | 23.2 (1.4) | 0.2 (–0.2 to 0.5) | 0.1 (–0.3 to 0.4) | 0.1 (–0.4 to 0.6) | 0.708 | 0.24 | ||
| Instrumental Activities of Daily Living*** | 18.4 (2.4) | 18.3 (4.0) | 1.7 (0.7 to 2.6) | 1.0 (0.1 to 1.9) | 0.7 (–0.7 to 2.0) | 0.316 | 0.24 | ||
*Statistically significant between group effects (p≤0.05) are printed in bold. **Mean differences between exergaming and control/comparison group resulting from the ANCOVA analysis. ***Instrumental Activities of Daily Living [63, 64]: maximum possible score is 23. A higher score indicates a higher level of autonomy. ****Activities of Daily Living [65]: maximum possible score is 24. A higher score indicates a higher level of function.
Outcome measures and between group effects* on emotional functioning by study and different comparison/control groups (if applicable)
| Baseline | Follow up at 8 weeks | ||||||
| Exergaming | Passive control group | Exergaming | Passive control group | ANCOVA** | Effect size | ||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-passive control group (95% CI) | (Cohen’s | ||
| Geriatric Depression Scale Short | 2.8 (1.5) | 1.0 (0.8) | 1.5 (1.3) | 1.5 (1.3) | 1.5 (0.3 to 2.7) | 0.644 | 0.00 |
| Exergaming | Active control group | Exergaming | Active control group | ANCOVA** | Effect size | ||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-active control group (95% CI) | (Cohen’s | ||
| Geriatric Depression Scale Short | 2.8 (1.5) | 2.2 (4.4) | 1.5 (1.3) | 2.0 (3.2) | 1.9 (0.2 to 3.7) | 0.459 | –0.34 |
| Exergaming | Cognitive intervention | Exergaming | Cognitive intervention | ANCOVA** | Effect size | ||
| Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Score (mean (SD)) | Exergaming-cognitive group (95% CI) | (Cohen’s | ||
| Geriatric Depression Scale Short | 2.8 (1.5) | 3.6 (4.9) | 1.5 (1.3) | 5.4 (3.8) | 3.5 (1.6 to 5.4) | 0.69 | –1.31 |
| Baseline | Follow up at 8 weeks | ||||||
| Exergaming Score (mean (SD)) | Comparison Score (mean (SD)) | Independent samples | |||||
| Exergaming group: change (mean (95% CI)) | Comparison group: change (mean (95% CI)) | Difference (95% CI) | Effect size (Cohen’s | ||||
| Activities-specific Balance Confidence scale*** | 83.2 (6.1) | 81.4 (7.3) | 5.6 (3.6 to 7.7) | –0.9 (–2.9 to 1.2) | 6.5 (3.6 to 9.4) | < | 1.23 |
| Falls Efficacy Scale**** | 16.7 (3.1) | 16.5 (2.9) | –3.7 (–5.7 to –1.7) | 1.1 (–0.9 to 3.1) | –4.8 (–7.6 to –2.0) | –1.53 | |
*Statistically significant between group effects (p≤0.05) are printed in bold. **Mean differences between exergaming and control/comparison group resulting from the ANCOVA analysis. ***Activities-specific Balance Confidence scale [66]: percentage of self-confidence, as indicator for functioning and risk of falling. ****Falls Efficacy Scale [67]: maximum possible score is 100. Lower scores indicate a greater confidence in maintaining daily living activities.
Risk of bias (quality) assessment
| Study | Risk of selection bias | Information about risk of selection bias | Risk of performance bias | Information about risk of performance bias | Risk of detection bias | Information about risk of detection bias | Risk of attrition bias | Information about risk attrition bias | Risk reporting bias | Information about risk of reporting bias | Risk of other bias | Overall risk of bias score |
| Bamidis et al. [ | High | No random allocation | High | No blinding of participants or staff | High | Not reported who conducted outcome assessments | High | No imputation of missing values | High | Not all separate outcome measures mentioned. No results on scores at pre- and post-test presented (only outcome analyses/ | Low | 5 out of 6 |
| Padala et al. [ | Low | Participants were randomized using a random number generator | High | No blinding of participants or staff | High | No blinding of outcome assessment | Low | Only 1 of 11 participants (in both intervention and control group) completed just 4 of 8 weeks of the study | Low | All outcome results are available in the (tables) of the paper | Low | 2 out of 6 |
| Padala et al. [ | Low | Subjects were randomized using a randomized block design to the intervention and walking control groups using sealed envelopes prepared by the statistician | High | No blinding of participants or staff | High | No blinding of outcome assessment | Low | 4 of 15 participants (in both intervention and control group) did not complete the study, however | Low | All outcome results are available in the (tables) of the paper | Low | 2 out of 6 |